|
Feb 17
|
Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now
|
|
Feb 16
|
AbbVie Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 15
|
Is AbbVie Stock a Buy Now?
|
|
Feb 14
|
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
|
|
Feb 14
|
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
|
|
Feb 13
|
AbbVie Declares Quarterly Dividend
|
|
Feb 13
|
AbbVie Inc. (ABBV): Among Lee Munder Capital Group’s Top Stock Picks
|
|
Feb 13
|
Neumora shakes up its C-suite; Biogen cuts early-stage pipeline
|
|
Feb 13
|
Is AbbVie Inc. (NYSE:ABBV) Trading At A 47% Discount?
|
|
Feb 13
|
AbbVie and Xilio to collaborate on antibody-based immunotherapies
|
|
Feb 12
|
Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
|
|
Feb 12
|
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
|
|
Feb 12
|
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
|
|
Feb 11
|
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
|
|
Feb 11
|
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
|
|
Feb 10
|
Gilead Sciences (GILD) Q4 Earnings: What To Expect
|
|
Feb 10
|
Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?
|
|
Feb 10
|
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
|
|
Jan 25
|
Is AbbVie Inc. (ABBV) The Best Bear Market Stock To Invest In Now?
|
|
Jan 24
|
AbbVie (ABBV) Stock Moves -0.22%: What You Should Know
|